SynthesisMalaria journal2025
Improving reproducibility of Plasmodium falciparum culture: a large-language-model-driven literature review and a parasite growth variability assessment of donor red blood cells.
Synthesis in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundIn vitro culture of Plasmodium falciparum forms the basis for many key malaria research areas globally, yet the human red blood cells (RBC) essential for culture remain poorly characterized in most studies, despite growing evidence of substantial donor-dependent variability that can influence parasite growth and experimental outcomes.
methodsA dual investigation was performed comprising: (1) a large language model-assisted systematic review of 963 PubMed-indexed articles (2000-2025) to assess reporting of RBC sourcing in malaria culture studies; and (2) an experimental analysis of parasite growth variability using standardized P. falciparum strain 3D7 culture with RBC from 69 malaria-naïve volunteers, including detailed haematological profiling of 24 participants.
resultsAmong the 963 studies, 314 provided explicit information on the RBC source. Of these, 61.1% failed to specify donor origin, 72.6% omitted blood group information, and only 6.0% reported the anticoagulant used. Type O RBC were used in 54.7% of studies reporting the blood group, despite limited evidence for biological advantage. In the experimental cohort, parasite growth after 96 h varied 6.4-fold across volunteers (range: 3.0-19.3), with growth phenotypes reproducible over three years. Low-growth volunteers had lower haemoglobin concentrations (12.3 vs. 14.8 g/dL, p = 0.03), more frequent personal or family history of anaemia (p = 0.01), and greater ancestry from malaria-endemic regions (p = 0.03). However, extended laboratory testing failed to identify any consistent clinical or biochemical predictors of growth capacity.
conclusionsDonor RBC are a major and reproducible source of biological variability in P. falciparum culture, yet are inconsistently reported and poorly understood. To address this, the STRuBeC (Standards for Reporting for use of (Red) Blood Cells in Culture) is proposed as a minimum reporting standard for studies using P. falciparum in vitro culture, to improve transparency, reproducibility, and cross-study comparability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.